Naloxone or other opioid antagonist; communication of information by Board of Pharmacy. (HB312)

Introduced By

Del. Wendy Gooditis (D-Clarke)

Progress

Introduced
Passed Committee
Passed House
Passed Senate
Signed by Governor
Became Law

Description

Board of Pharmacy; information about naloxone. Directs the Board of Pharmacy to include in each annual license renewal communication information about the dispensing, possession, and administration of naloxone or other opioid antagonist, including information about laws governing the dispensing, possession, and administration of naloxone or other opioid antagonist and civil immunity for individuals who administer naloxone or other opioid antagonist to a person believed to be experiencing an opioid overdose. Read the Bill »

Outcome

Bill Has Failed

History

DateAction
12/31/2019Committee
12/31/2019Prefiled and ordered printed; offered 01/08/20 20101561D
12/31/2019Referred to Committee on Health, Welfare and Institutions
01/13/2020Impact statement from DPB (HB312)
01/28/2020Stricken from docket by Health, Welfare and Institutions (22-Y 0-N) (see vote tally)

Post a Public Comment About this Bill



if you have one


(Limited HTML is OK: <a>, <em>, <strong>, <s>)